Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Virpax Selects Kindeva Drug Delivery as Development Partner | Contract Pharma

What are you searching for?

Sign in
Breaking News, Collaborations & Alliances

Virpax Selects Kindeva Drug Delivery as Development Partner

Will bring Diclofenac pMDI from an existing lab-scale formulation to a phase II and III clinical supply.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Virpax Pharmaceuticals and Kindeva Drug Delivery have entered a partnership to work together to advance the clinical program of the Virpax-developed Diclofenac topical spray film (Epoladerm) in the U.S. The product is being studied for the treatment of pain associated with osteoarthritis of the knee. Using Kindeva’s state-of-the-art facilities located in Woodbury, MN, they will bring this product from an existing lab-scale formulation to a phase II and III clinical supply.

“We are excited to continue to advance our product development strategy for Epoladerm by collaborating with a strong partner who has demonstrated expertise in developing and manufacturing complex products for large-scale production,” said Anthony P. Mack, CEO of Virpax.

Aaron Mann, CEO of Kindeva Drug Delivery, said, “We are pleased to support Virpax in their ongoing development of Epoladerm. This application of our deep expertise with aerosol delivery, transdermal drug development, and combination products is further validation of Kindeva’s strategy.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics